SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.260
+0.160 (5.16%)
Dec 20, 2024, 4:00 PM EST - Market closed
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $216.59 million as of December 20, 2024. Its market cap has decreased by -20.06% in one year.
Market Cap
216.59M
Enterprise Value
152.48M
1-Year Change
-20.06%
Ranking
Category
Stock Price
$3.26
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $216.59M, a decrease of -80.67%. That is a compound annual growth rate of -38.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 216.59M | -29.40% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| LifeMD | 218.29M |
| Cardiff Oncology | 217.83M |
| Profound Medical | 217.45M |
| Alpha Tau Medical | 216.76M |
| Inhibikase Therapeutics | 215.02M |
| Zentalis Pharmaceuticals | 213.80M |
| Inhibrx Biosciences | 211.35M |
| Acrivon Therapeutics | 208.92M |